Status:
COMPLETED
Effect of Vitamin D Supplementation on Inflammatory Markers
Lead Sponsor:
Université d'Auvergne
Conditions:
Vitamin D Deficiency
Type2 Diabetes
Eligibility:
All Genders
60-72 years
Phase:
NA
Brief Summary
Previous studies have shown that improving vitamin D status among the elderly may lead to an improvement in some inflammatory markers, especially with patients with type 2 diabetes. The aim of our tri...
Detailed Description
Vitamin D was shown crucial for insulin secretion and glucose homeostasis. Furthermore, one of the markers of type 2 diabetes is low-grade inflammation, which can be the result of an elevated circulat...
Eligibility Criteria
Inclusion
- Subjects deficient in vitamin D
- Subjects having type 2 diabetes
- Non-obese subjects
Exclusion
- Subjects having hyperparathyroidism
- Subjects suffering from hepatic disease / kidney disease
Key Trial Info
Start Date :
May 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 9 2018
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT03782805
Start Date
May 9 2018
End Date
July 9 2018
Last Update
December 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Charles Hospital
Beirut, Lebanon, 64